LicianPro

Chris Schott

Equity research analyst · J.P. Morgan

Earnings calls

1

Nov 5, 2026 – Nov 5, 2026

Stocks asked about

1

Questions

2

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Chris Schott asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 1:01:24
      “Following the recent... Sierra Deal, just curious on how you're thinking about capital deployment and BD priorities from here. And then the second question would be, I think you noted that you secured first the file status for Wegovia in the call. Just curious how you're…”
    • 1:02:33
      “And then we go the tablet, 25 milligram. Yes, we said that we secure the first file. Again, that's for the tablet. But as you know, we've had a significant uh, offering for GLP-1s in the future, where we basically developed every presentation for semaglutide, but also for…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

J.P. Morgan rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Chris Schott. We do not use licensed rating databases.

No rating action by J.P. Morgan on these stocks in the headlines we store yet.